Haibo Zhao
Key Laboratory Of Biological Targeting Diagnosis
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A Preliminary Report on the Safety and Efficacy of a Novel CT-Guided Puncture Device for Adult Percutaneous Nephrolithotomy.
Journal: Journal of endourology
Published: February 06, 2026
MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic response.
Journal: World journal of surgical oncology
Published: December 10, 2025
In situ study on the thermoelectric properties of monolayer MoS2 film.
Journal: The Review of scientific instruments
Published: November 13, 2025
Metastatic pericardial mass and cardiophrenic lymph nodes resection in ovarian cancer.
Journal: Gynecologic oncology reports
Published: March 06, 2024
Experimental and numerical investigation of the transient thermal characteristics of twisted nitinol wires in a continuous torsional refrigeration system.
Journal: PloS one
Published: February 14, 2022
Risk Scores Based on Six Survival-Related RNAs in a Competing Endogenous Network Composed of Differentially Expressed RNAs Between Clear Cell Renal Cell Carcinoma Patients Carrying Wild-Type or Mutant Von Hippel-Lindau Serve Well to Predict Malignancy and Prognosis.
Journal: Frontiers in oncology
Published: June 17, 2021
Swerchirin exerts anticancer activity on SKOV3 human ovartian cancer cells via induction of mitochondrial apoptosis, G2/M cell cycle arrest and inhibition of Raf/MEK/ERK cascade.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: March 15, 2021
Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy.
Journal: Journal of molecular recognition : JMR
Published: November 16, 2020
Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer.
Journal: Frontiers in cell and developmental biology
Published: October 12, 2020
Erratum: MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma.
Journal: Molecular and clinical oncology
Published: May 27, 2020
Last Updated: 09/26/2026